CAS 905281-76-7
:2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-pyridin-4-yl-1H-pyrazol-1-yl}ethanol
Description:
The chemical substance known as 2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-pyridin-4-yl-1H-pyrazol-1-yl}ethanol, with the CAS number 905281-76-7, is a complex organic compound characterized by its multi-functional structure. It features a hydroxylamine moiety, which is indicative of its potential reactivity and ability to form hydrogen bonds, enhancing its solubility in polar solvents. The presence of a pyrazole and pyridine ring suggests that it may exhibit interesting biological activities, possibly acting as a ligand or inhibitor in various biochemical pathways. The indene derivative contributes to its unique three-dimensional conformation, which may influence its interaction with biological targets. Additionally, the ethanol group suggests that it may have applications in medicinal chemistry, particularly in drug design, due to its potential for modulating biological activity. Overall, this compound's structural complexity and functional groups make it a candidate for further investigation in pharmacological studies.
Formula:C19H18N4O2
InChI:InChI=1/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2/b22-18+
Synonyms:- Gdc-0879
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
GDC-0879 Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications GDC-0879 is a RAF inhibitor used in the treatment of melanoma tumors associated with the BRAF serine/threonine kinase.<br>References Hoeflich, K. et al.: Canc. Res., 69, 3042 (2009); Hansen, J. ET AL.: Bioorg. Med. Chem. Lett., 18, 4692 (2008);<br></p>Formula:C19H19ClN4O2Color and Shape:NeatMolecular weight:370.83GDC-0879
CAS:GDC-0879 (AR-00341677) is a novel, potent and selective B-Raf inhibitor with IC50 of 0.13 nM with activity against c-Raf as well.Formula:C19H18N4O2Purity:99.62%Color and Shape:SolidMolecular weight:334.37



